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Virus yieldThe production of virus by infected cells is an essential process for the spread and persistence of viral diseases, the
effectiveness of live-viral vaccines, and themanufacture of viruses for diverse applications. Yet despite its impor-
tance, methods to precisely measure virus production from cells are lacking. Most methods test infected-cell
populations, masking how individual cells behave. Here we measured the kinetics of virus production from
single cells. We combined simple steps of liquid-phase infection, serial dilution, centrifugation, and harvesting,
without specialized equipment, to track the production of virus particles from BHK cells infected with vesicular
stomatitis virus. Remarkably, cell-to-cell differences in latent times to virus release were within a factor of two,
while production rates and virus yields spanned over 300-fold, highlighting an extreme diversity in virus produc-
tion for cells from the same population. These ﬁndings have fundamental and technological implications for
health and disease.
© 2011 Elsevier Inc. All rights reserved.Introduction
When a virus infects a cell, it hijacks resources of the cell tomanufac-
ture and release a new generation of progeny virus particles. The result-
ing cycle of virus production at the cellular level is an essential part of
diverse natural and engineered processes, including: the spread and
persistence of infectious diseases such as AIDS, inﬂuenza, and the
common cold (Flint et al., 2009; Levin et al., 1999); the activation of
immune responses within virus-infected hosts (Murphy et al., 2008);
the design of attenuated viruses for vaccines (Lim et al., 2006); the
use of viruses to treat cancers (Melcher et al., 2011), and the large-
scale production of viruses for health applications (Lohr et al., 2010).
Yet despite its central importance, methods to precisely quantify virus
production at the cellular level are lacking. Most approaches measure
the production of virus by sampling from a population of infected
cells, providing average values that mask the potentially wide-ranging
and signiﬁcant behaviors of individual cells.
Within a laboratory culture of virus-infected cells, or within a tissue
of an infected host, individual cells can diverge in behavior from the
average or majority of infected cells. However, these rare cells may
nevertheless contribute importantly to the long-term behavior of the
infection, well beyond their initial encounter with the virus. For
example, in the presence of an anti-viral drug, some cells may produce
higher than average levels of virus progeny, behavior that can arise fromengr.wisc.edu (J. Yin).
rights reserved.infection by drug-resistant virus (Larder et al., 1990). Over multiple cy-
cles of growth, selection of such drug-resistant viruses can enable them
to dominate the virus population (Condra et al., 1995), whichmay con-
tribute toward the progression and spread of disease. Alternatively, in
culture only a small fraction of virus-infected dendritic cells appear to
trigger an initial innate defensive response, which is subsequently am-
pliﬁed to create an anti-viral state across a majority of cells (Hu et al.,
2011). Moreover, the activation of such innate immune responses in
vivo shapes the development of adaptive immune responses that im-
pact recovery from infection and establishment of long-term immunity
(Guidotti and Chisari, 2001). Further, some infected cells may adopt a
state of non-progressive infection or latency, permitting them to
evade clearance by immune defenses until re-activation by environ-
mental or other cues (Kutsch et al., 2002). These examples suggest
how a minority of initial infected cells, in vitro or in vivo, may deviate
from the average infected-cell behavior yet contribute disproportion-
ately, over the longer-term, to the extent or nature of infection spread.
Because these rare-cell behaviors are generally obscured during
average-cell measures of infection, they highlight the need for single-
cell measures of behavior that can be readily performed on many indi-
vidual cells to reveal the extent of cell heterogeneity.
To date, limited studies have focused on the production of virus from
single infected cells. In a classic study Burnet incubated andplated dilut-
ed phage stocks with excess bacteria and quantiﬁed phage released
from different samples at different time points, providing early
evidence for the step-like production of phage from their host cells
(Burnet, 1929). Further, the study of phage-infected bacterial cells
allowed measures of total ‘burst sizes’ of phage progeny from multiple
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1000 phage per cell (Delbrück, 1945). We extended these approaches
to amammalianRNA virus, vesicular stomatitis virus (VSV), by infecting
single cells with single virus particles, and we found infected cells pro-
duced yields from below 50 to over 8000 virus particles (Zhu et al.,
2009a). Further, Cuevas et al. studied the kinetics of VSV production
from individual infected cells that were sequentially sampled and ana-
lyzed, providing initial release proﬁles of virus progeny (Cuevas et al.,
2005). However, this study allowed for production of virus from sec-
ondary infections, limiting interpretation of single-cell behavior only
to the earliest stages of virus release.
Here we demonstrate a method to measure the kinetics of virus
production from individual cells, without confounding effects from
secondary infections. Our method combines a series of simple steps
that can be performed in any cell biology or virology facility, without
reliance on specialized equipment (Fig. 1a). We isolate single infected
cells, perform multiple harvest-and-replenish steps on the liquid
medium in the cell's environment, followed by measurement of infec-
tious virus titer by plaque counting, enabling us to construct a kinetic
proﬁle of virus production for each cell. Integration of the virus counts
gives a cumulative production or “one-step” curve, from which we
calculate quantitative features of virus production from each cell
(Fig. 1b): latent time — the time interval between entry of adsorbed
virus into its host cell and initial release of virus progeny, rise time —
the time interval over which the cell produces virus, yield— the cumu-
lative total of virus produced by the infected cell, and rise rate — the
average rate of virus production from a cell (yield/rise time). We dem-
onstrate our method by infecting BHK cells with vesicular stomatitis
virus (VSV), a model RNA virus. VSV is the focus of on-going studies
that are advancing an integrated understanding of how virus-cell inter-
actions impact the kinetics of virus growth and infection spread, as well
as the evolutionary dynamics of virus populations (Cuevas et al., 2005;
Haseltine et al., 2008; Lam et al., 2005; Lim et al., 2006; Novella et al.,
1995; Turner and Elena, 2000; Zhu et al., 2009b).Results
Virus production rates from single cells
BHK cells were released from their culture surfaces by treatment
with trypsin, counted, cooled on ice, and mixed with excess VSV (MOI
5) in the cold, to enable virus to bind to cell surfaces without fusion
and entry. Infected cells were serially diluted so an aliquot containing
on average less than one cell per well could be added to each well of a
96-well plate, plates were subjected to centrifugation to adhere cells
to the bottom surface of each well, and wells containing single cells
were identiﬁed by microscopy. Cell locations within each well were
marked to indicate areas to avoid disruption during sample-replenish
steps, and plates were incubated to initiate infections. A total harvest
and replenishment of liquid media was performed at set intervals to
capture the released virus progeny from each cell, and virus within
each sample was measured by plaque assay.
From a sampling of twenty-four wells, each containing a single cell,
12wells produced plaque counts fromwhich rates of virus releasewere
calculated over the full time-course of the virus growth cycle (Fig. 2a).
Cells initiated release of virus between 3.5 and 6.5 hours post infection
(hpi), and once initiated, different cells released virus progeny at vastly
different rates, spanning from 10 to 3000 plaque-forming units (PFU)
per hour, with an average maximum production rate of 1200±
1000 PFU/h (±1 S.D.). Generally, cells produced virus between 4 and
12 hpi, and in most cases (8 of 12) virus production rates exhibited aFig. 1. Kinetics of virus release from single infected cells. (a) Our method combines steps of v
(b) one-step virus release proﬁles, from which one can estimate parameters of single-cell vsingle-peaked value. Possiblemechanisms for two-peak production, ap-
parent in Fig. 2a (C7, A3, C8, A2),would include infections initiated from
a cell that subsequently divided, so supernatant sampling could reﬂect
the sum of different virus production proﬁles from two cells. Alterna-
tively, the two-peak behavior might reﬂect the complex coupling be-
tween intracellular processes that promote virus production and host
cellular defenses that may inhibit virus production. By calculating the
cumulative release of virus particles at each sample time we generated
one-step virus production curves for single cells (Fig. 2b). Here, 12
infected cells produced an average yield of 3700±3800 PFU (±1
S.D.), with virus production from individual cells spanning from 30 to
10,000 PFU, a range of more than 300-fold.
Although each cell was exposed to an excess of ﬁve infectious
virus particles (MOI 5), not all cells were productive. Several factors
may be relevant. First, our conditions for solution-phase adsorption
of virus particles to cells may be insufﬁcient to ensure that every
cell is infected. Second, virus that initiates infection may not carry
through the process to production of progeny. We have previously
found that cells infected by a recombinant GFP-virus could produce
GFP without producing detectable virus (Zhu et al., 2009a), indicating
infections may terminate after initial gene expression. Finally, cells
may have been inadvertently removed during sampling. Our method,
which aims to minimize loss or removal of cells by sampling distant
from their initial adsorption location, may nevertheless be too disrup-
tive to retain each cell over the entire sampling period.
Integrated kinetics of virus production
For each of 12 cells we estimated the latent time, rise rate, yield and
rise time from its one-step production curve. Plots of yield or rise rate
versus latent time show orders of magnitude variation in yield and
rise rate, while latent times were narrowly distributed (Figs. 3a/b, left
panels). On linear plots longer latent times corresponded to both higher
yields and higher rise rates (Figs. 3a/b, right panels). Yields strongly
correlated with rise rates (Fig. 3c), a result that follows from the deﬁni-
tion of rise rate (yield per rise time), the very broad distribution of
yields, and the relatively narrow distribution of rise times. Yields corre-
latedwith rise times, where higher yields correspondedwith longer rise
times (Fig. 3d). Here it was also apparent that more productive cells
were not as variable in their rise times as the less productive cells;
speciﬁcally, cells producing fewer than 1000 PFU spanned a broader
range of rise times than cells producing higher yields. Finally, cells
that initiated release of virus progeny later also spent more time active-
ly producing virus (Fig. 3e).
Error propagation in the plaque assay
Our estimated propagation of error from pipetting and plaque
counting was comparable to the observed error over a wide range of
virus concentrations that includedmore than 90% of themeasurements
in this study. Observed errors only exceeded estimated errors at lowest
concentrations, below 4 PFU per 100 μl, representing less than 10% of
the one-step infection measurements in this study. The single-cell
one-step infectionswereminimally affected by this result. An exception
was the single-cell that produced only 34 PFU, where the actual yield
could be up to 40% higher.
Dependence of single-cell yield on multiplicity of infection
BHK cells were infected in solution at MOI 5, 10, 15, 20, 30, 40, and
80 PFU per cell. At each MOI, 10-to-12 wells containing single-cellsirus infection, cell immobilization by adsorption, multi-time sampling, and analysis, and
irus production: latent time, rise rate, yield and rise time.
Fig. 2. Virus production proﬁles for virus-infected cells. (a) Production rate proﬁles for 12 cells drawn from the same initial population of infected cells, and (b) one-step production
of virus from single cells.
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infected cell to dislodge from the surface of the well; for example,
three out of ten cells infected at MOI 80 were dislodged from their
wells during the washing step, so these cells were not included in the
analysis. For each MOI, the mean of the yields from at least seven cells
was determined, as shown in Fig. 4a. The error bars represent one stan-
dard deviation about the mean. Yields at MOI 5 and MOI 15 were not
signiﬁcantly different (p-value 0.076).
The average yield measured at MOI 5 (Fig. 4a) was found to be con-
sistent with the average of the cumulative yields from the single-cell
kinetic measures (Fig. 2b). The average yield measured at MOI 5 was
4170±4680 PFU per cell, which was not signiﬁcantly higher than the
average cumulative yield from the kinetic measures (p-value 0.60).
The yield distributions from both experiments spanned a similar
range (Fig. 4b).Discussion
Single infected cells drawn from the same population produced
virus particles spanning a broad range — from 30 to 10,000 plaque -
forming units (PFU). This broad distribution in virus production
could be attributed to variation across the virus population, since
RNA viruses such as VSV are known for their mechanisms for gener-
ating extreme genetic heterogeneity (Domingo et al., 1985), and we
previously found low-yield behaviors that were transferable from
one generation to the next (Zhu et al., 2009a). We thought it possible
that the distribution of yields could reﬂect different numbers of virus
particles that adsorb to individual cells when they are treated with
excess virus (MOI 5), but the average yield from single-cells infected
at higher MOIs did not change signiﬁcantly (Fig. 4a). The broad distri-
bution may well reﬂect different stages of the cell cycle, which could
Fig. 3. Correlations among virus-release traits from single cells. Cells that produce virus earlier (shorter latent times) tend to produce fewer virus particles at slower rates as indi-
cated by (a) yield vs latent time and (b) rise rate vs latent time; (c) yields and rise rates are correlated owing to relatively narrow distributions among rise times, (d) larger yields
require a longer period of virus production, and (e) earlier producers tend to be productive for shorter periods than later producers.
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computational modeling of VSV early kinetics suggests that the
intrinsic noise or stochasticity associated with early intracellular
replication can give rise to further six-fold differences in genomic
template levels (Hensel et al., 2009), but how such differences impact
virus production remain to be determined. In a study of phage T7, a
DNA virus that infects bacteria, we found that richer nutrient condi-
tions promoted faster cell growth, as well as earlier and faster pro-
duction of phage particles within cells, and computational modeling
highlighted links between phage production and capacity of the
cellular resources for protein synthesis (You et al., 2002). Taken
together, these studies suggest that the broad range of virus yields
from different cells reﬂects potentially diverse factors: viral geneticFig. 4. Virus yields from single infected cells. (a) Dependence of single-cell yields onMOI. Averag
equal variance, 95% conﬁdence interval). Error bars at eachMOI reﬂect one standard deviation o
(MOI 5 yield) and the kinetic experiment (MOI 5 cumulative yield) where the average yields dvariation, cell-to-cell variation in resources, and the noisy kinetics
associated with small numbers of virus molecules present during
the early stages of growth.
While our method for the study of virus release from single cells
offers a new perspective on diversity of kinetic proﬁles and virus yields,
generalization of the method for the study of other viruses will need to
address several points. First, we have synchronized infections by using
excess virus and adsorbing them to cells in the cold, a process that
holds adsorbed virus in a pre-fusion (pre-infection) state that may be
used to simultaneously trigger infection upon incubation. Viruses that
enter their host cells by other mechanisms may require other ap-
proaches to synchronize their infections. Second, we used centrifugal
forces to drive cell contact and adhesion to culture plates, but othere single-cell yields atMOI 5 andMOI 15did not differ (p-value 0.076, Student's t-test, non-
f the average yield. (b) Yield distribution from single-cells from theMOI-series experiment
id not differ (p-value 0.60, Student's t-test, non-equal variance, 95% conﬁdence interval).
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between cells and the culture surfacesmay be needed for other systems.
Third, we employed the standard plaque assay to quantify the release of
viable virus particles. Other approaches might well use the polymerase
chain reaction (PCR) to quantify viral genomes or biochemical analyses
of viral constituents to quantify other correlates of virus production.
Finally, in its current implementation our method is likely to be too
labor intensive for high-throughput analysis of hundreds or thousands
of individual cells. Less time- and labor-intensive approaches may
emerge from advances in microscale technologies that, for example,
employ ﬂow-enhanced quantiﬁcation of infections initiated by single
infected cells (Zhu et al., 2009b; Zhu and Yin, 2007).
Conclusions
We have shown that it is possible to study viral release kinetics
from single infected cells. Such single-cell measures reveal details
about the virus–host biology that are not possible to extract from
population-level measures. Speciﬁcally, by performing such measures
on multiple cells one can gain an appreciation for how traits of virus
growthmay be distributed and correlated. These observationsmotivate
new questions on how genetic, environmental and other factors impact
virus–host interactions.
Materials and methods
Cell type and virus strain
Baby hamster kidney cells (BHK-21) adapted for infection, origi-
nally from Isabel Novella, were used in all experiments. Cells were
passaged approximately every two days and maintained in media
composed of 1× Minimum Essential Medium with Earle salts (MEM,
Cellgro) supplemented with 10% fetal bovine serum (FBS, Atlanta Bio-
logicals) and 2 mM GlutaMAX (Gibco). The media used for infections
was MEM supplemented with 2% FBS and 2 mM GlutaMAX. The VSV
strain used is a recombinant strain (N1) encoding VSV genes in the
same order as the wild-type virus (Wertz et al., 1998), generously pro-
vided by Gail Wertz.
Single cell infections
General protocol
Monolayers of BHK-21 cells grown in 75 cm2 cell culture ﬂasks
were released with 2 ml 0.05%trypsin/0.53 mM EDTA (Cellgro) after
washing with Dulbecco's phosphate buffered saline (DPBS, Gibco).
The trypsin was neutralized with 8 ml infection media and the cell
suspension was placed in a 15 ml conical tube. Cell counts were deter-
mined by hemacytometer. The cell suspension was put on ice, cooled
virus solution was added, and the suspension was mixed thoroughly
every 5 min over 30 min to minimize cell aggregation and allow for
virus attachment to cells without entry. The cell suspension was then
serially diluted in cold media to less than 1 cell per 100 μl and then
added to a 96-well plate (100 μl/well). The plate was centrifuged at
1000 rpm and 4 °C for 3 min to promote cell deposition and attachment
to the plate, and the plate was incubated at 37 °C allowing initiation of
infection by endocytosis (Miller and Lenard, 1980).
Virus stock preparation
Virus stock was created using virus produced from a single cell.
Following the general protocol for single-cell infections, BHK-21
cells were infected with VSV at an MOI of 5 and an extra 100 μl of
media was added to each well. At 13.5 hours post infection (hpi),
samples were taken from 5 wells containing single cells. 50 μl was
used to determine the titer of the sample and the rest was reserved
for a future infection. A high titer samplewas used to infect amonolayer
of cells at low MOI (~0.0003), supernatant was collected at 16 hpi,centrifuged to remove cell debris, ﬁltered, aliquoted, and stored at
−80 °C for future use.
Determination of effective virus titer
An effective titer for the single-cell stock virus was determined by
following a procedure similar to the single-cell infection protocol. A
100-fold dilution of stock virus was added to a concentrated cell sus-
pension (1.85×106 cells/ml), giving about two virus particles per cell,
and this solution was maintained on ice for 30 min. This concentration
was added tomimic the highmultiplicity conditions of the actual infec-
tions, but reduce the probability that single cells would be infected by
multiple virus particles. The solution was mixed thoroughly every
5 min, to minimize cell aggregation. The virus-attached cell suspension
was serially diluted in cell suspensions of equal density, so that only the
virus-attached cell density was reduced. These cell suspensions were
warmed for 3 min in a water bath set to 37 °C to allow attached virus
to endocytose. The suspensions were centrifuged at 4 °C and
1000 rpm for 5 min to pellet the cells. The supernatant containing any
unattached virus was decanted and the pellets were washed gently
with DPBS. The cell pellets were re-suspended and added to wells of a
6-well plate. The cells were allowed 1 h to settle to attach to the bottom
of thewell. At this time, most of the cells were adhered. Themonolayers
were washed with DPBS and overlaid with an agar solution (0.6% Difco
Agar Noble dissolved in sterile water which makes up 10% of the total
volume and 90% infection media by volume). After incubating for
22 h, the agar gels were removed and the cells were ﬁxed with a para-
formaldehyde (PFA) solution (4% paraformaldehyde and 5% sucrose in
10 mM phosphate buffered saline (PBS, Sigma)), rinsed twice with
PBS, and stained with 0.1% crystal violet in 20% ethanol. The plaques
were counted and the effective titer of the original stock solution was
determined, taking into account all the serial dilutions and the initial
amount of virus added to the cell solution.
Typically, for these experiments, the density of the cell solution
was about 106 cells/ml. A small volume of concentrated virus solution
was added so that the cell solution would not be diluted signiﬁcantly
when adding a high multiplicity of virus. In this case 86 μl of virus was
added to 1 ml of cell solution. Sufﬁcient virus was added to infect ap-
proximately 60% of the cells in the original suspension.
Single-cell one-step infection
The general protocol for single-cell infections was followed. The cell
solution was infected at MOI 5 based on the effective titer of the single-
cell virus stock. This MOI was chosen to ensure a large percentage of
cells would become infected. The virus-attached cell solution ﬁlled
three 96-well plates. One row of one platewas used for control samples.
The plates were removed one at a time from the 37 °C incubator and
placed in an environmentally controlled chamber (LiveCell fromPathol-
ogy Devices) maintaining the cells at 37 °C, 5% CO2, and approximately
75% humidity, on a Nikon Eclipse TE300 microscope. The plates were
scanned for wells containing individual cells, and the location of the
cell in the well was recorded. To limit time outside the incubator for
sampling, only eight wells were chosen per plate. The ﬁrst sample was
taken at 2 hours post infection (2 h post warming to 37 °C) well before
the release of any virus progeny. To minimize perturbation of the cell,
all 100 μl of infection media was slowly removed by pipette, distant
from the cell, and then slowly replaced with fresh warm infection
media at the same location. This procedure was repeated for each of
the 24 selectedwells. Each sampling removed plates from the incubator
for 6–7 min. Samples were taken from 2 to 24 hours post infection.
After the ﬁnal sample was taken an additional wash (100 μl of media)
was added and mixed thoroughly to dislodge any virus that had
adhered to the well. All samples were stored at −80 °C immediately
after sampling until virus detection with plaque assay. Control samples
and washes from the control wells were collected from 2 to 14 h after
addition of virus.
17A. Timm, J. Yin / Virology 424 (2012) 11–17Quantiﬁcation of virus production
Virus in each sample was measured by plaque assay. The low levels
of virus and small volumes of sample in the single-cell infections
excluded the possibility for replicatemeasures. In all cases 200 μl of var-
ious sample dilutions was used to infect BHK cell monolayers in 6-well
plates. The virus was permitted 1 h to adsorb at 37 °C, the monolayers
were washed with 2 ml DPBS, and then overlaid with an agar solution.
The plates were incubated 24 h before ﬁxation and staining. Samples
were diluted 1:3 and then serially diluted 1:10 to ensure that very
small amounts of virus could be detected.
Error propagation was estimated based on contributions from
pipetting and plaque counting. The error in plaque counting, approx-
imated as the square root of the total plaques counted, and measure-
ment error from our pipettes, as supplied by the manufacturer, were
propagated and compounded as described elsewhere (Hughes and
Hase, 2010). The results of the error propagation calculations should
represent the maximum possible error. To conﬁrm that this error ex-
ceeds the actual error, a stock of virus (9700 PFU/100 μl) was made
and serially diluted, by factors of three down to approximately
1 PFU/100 μl. These stocks were separated into three aliquots and fro-
zen at −80 °C until quantiﬁcation with plaque assay. The procedure
for diluting the aliquots and quantifying by plaque assay was done
in the same manner as the one-step samples, but duplicate measures
were taken and the stock aliquots were quantiﬁed on three separate
occasions.
To test for correlations between early and middle stages of virus
release and the total virus yield, we assembled cumulative one-step
curves for virus production and estimated the yield, rise rate, latent
time, and rise time. The yield is simply the cumulative number of
progeny virus produced by a single cell. The rise rate is estimated
from the slope of the cumulative virus production curve, based on
three data points through the half-yield level. Extrapolation of the
line through these data to the time axis provides the latent time, indi-
cating the time scale for the earliest release of progeny virus. Finally,
the rise time is the length of the period over which virus particles are
released (yield per rise rate).Dependence of single-cell yield on multiplicity of infection
Cellswere infected in solution across a range ofMOI 5-to-80 PFU per
cell following the procedure described in the General protocol section.
Excess virus not adsorbed was removed 2.5 hpi (before release of prog-
eny virus) and samples were collected 24 hpi and quantiﬁed as de-
scribed in the section on Quantiﬁcation of virus production. Student's
t-test was used to determine if the differences in average yields at
MOIs 5 and 15 were statistically signiﬁcant. At MOI 5 and MOI 15
there were 11 data points and the variances were not assumed to be
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